Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 | 2018 | 235 | 2.13 | Why? |
| Antibodies, Antineutrophil Cytoplasmic | 6 | 2018 | 140 | 1.95 | Why? |
| Glomerulonephritis | 3 | 2018 | 226 | 1.69 | Why? |
| Microscopic Polyangiitis | 3 | 2018 | 31 | 1.62 | Why? |
| Fabry Disease | 2 | 2019 | 106 | 1.36 | Why? |
| Systemic Vasculitis | 2 | 2018 | 74 | 1.28 | Why? |
| Giant Cell Arteritis | 2 | 2017 | 137 | 1.13 | Why? |
| Granulomatosis with Polyangiitis | 3 | 2019 | 161 | 0.93 | Why? |
| Churg-Strauss Syndrome | 2 | 2019 | 61 | 0.91 | Why? |
| Kidney Failure, Chronic | 4 | 2018 | 3222 | 0.90 | Why? |
| Nucleic Acid Synthesis Inhibitors | 1 | 2019 | 43 | 0.77 | Why? |
| Liver Cirrhosis, Biliary | 1 | 2019 | 42 | 0.76 | Why? |
| Guanine | 1 | 2019 | 146 | 0.72 | Why? |
| Sarcoidosis | 2 | 2019 | 271 | 0.71 | Why? |
| Cholangitis | 1 | 2019 | 81 | 0.70 | Why? |
| Rosa | 1 | 2017 | 18 | 0.69 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2018 | 113 | 0.69 | Why? |
| Collagen Type IV | 1 | 2017 | 12 | 0.69 | Why? |
| Surgical Sponges | 1 | 2017 | 17 | 0.68 | Why? |
| Complement Inactivating Agents | 1 | 2020 | 254 | 0.68 | Why? |
| Hemostasis, Surgical | 1 | 2017 | 29 | 0.67 | Why? |
| Aprotinin | 1 | 2017 | 63 | 0.65 | Why? |
| Azathioprine | 1 | 2017 | 161 | 0.65 | Why? |
| Thrombotic Microangiopathies | 1 | 2020 | 335 | 0.63 | Why? |
| Corneal Diseases | 1 | 2018 | 172 | 0.62 | Why? |
| Vasculitis | 3 | 2018 | 691 | 0.62 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2017 | 86 | 0.62 | Why? |
| Tenofovir | 1 | 2019 | 449 | 0.58 | Why? |
| Hepatitis, Autoimmune | 1 | 2019 | 254 | 0.56 | Why? |
| Proteinuria | 1 | 2018 | 474 | 0.56 | Why? |
| Chemokine CCL2 | 1 | 2017 | 389 | 0.55 | Why? |
| Thrombin | 1 | 2017 | 325 | 0.53 | Why? |
| Cardiovascular Surgical Procedures | 1 | 2017 | 281 | 0.51 | Why? |
| Russia | 4 | 2020 | 989 | 0.48 | Why? |
| Hepatitis B, Chronic | 1 | 2019 | 616 | 0.46 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 595 | 0.44 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.43 | Why? |
| Autoantibodies | 2 | 2018 | 2094 | 0.40 | Why? |
| Motivation | 1 | 2020 | 1640 | 0.39 | Why? |
| Arthritis, Rheumatoid | 2 | 2020 | 2043 | 0.37 | Why? |
| Rheumatology | 1 | 2019 | 1213 | 0.37 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.34 | Why? |
| Lung Diseases, Interstitial | 1 | 2018 | 1476 | 0.33 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.32 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.27 | Why? |
| Rheumatic Diseases | 1 | 2020 | 2675 | 0.27 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.25 | Why? |
| Intensive Care Units | 5 | 2020 | 29594 | 0.23 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.23 | Why? |
| Finger Joint | 1 | 2020 | 18 | 0.22 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.21 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.20 | Why? |
| Membrane Potentials | 1 | 2019 | 56 | 0.20 | Why? |
| alpha-Galactosidase | 1 | 2019 | 32 | 0.20 | Why? |
| Amino Acids, Essential | 1 | 2018 | 2 | 0.19 | Why? |
| Interleukin-5 | 1 | 2019 | 138 | 0.19 | Why? |
| Humans | 36 | 2021 | 930598 | 0.19 | Why? |
| Myeloblastin | 1 | 2018 | 57 | 0.19 | Why? |
| Hepatitis B e Antigens | 1 | 2019 | 99 | 0.19 | Why? |
| Pelvis | 1 | 2019 | 125 | 0.18 | Why? |
| Polyarteritis Nodosa | 1 | 2017 | 25 | 0.18 | Why? |
| Autonomic Nervous System Diseases | 1 | 2019 | 67 | 0.18 | Why? |
| Diet, Protein-Restricted | 1 | 2018 | 80 | 0.18 | Why? |
| Fibroblast Growth Factors | 1 | 2018 | 119 | 0.17 | Why? |
| Glucuronidase | 1 | 2018 | 103 | 0.17 | Why? |
| Nephritis, Interstitial | 1 | 2018 | 83 | 0.17 | Why? |
| Glomerulonephritis, IGA | 1 | 2018 | 115 | 0.17 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.16 | Why? |
| Abatacept | 1 | 2017 | 192 | 0.15 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.15 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.15 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2016 | 393 | 0.15 | Why? |
| Hemostatics | 1 | 2017 | 142 | 0.15 | Why? |
| Rheumatologists | 1 | 2019 | 346 | 0.15 | Why? |
| Blood Loss, Surgical | 1 | 2017 | 211 | 0.14 | Why? |
| Cornea | 1 | 2018 | 410 | 0.14 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.14 | Why? |
| Arthritis, Psoriatic | 1 | 2020 | 625 | 0.13 | Why? |
| Scleroderma, Systemic | 1 | 2020 | 583 | 0.13 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.12 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.12 | Why? |
| Biological Therapy | 1 | 2017 | 456 | 0.12 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.12 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.12 | Why? |
| Hepatitis B virus | 1 | 2019 | 882 | 0.11 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.11 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.11 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.11 | Why? |
| Immune System | 1 | 2020 | 1479 | 0.10 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2020 | 6166 | 0.10 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.10 | Why? |
| Heart | 1 | 2019 | 1791 | 0.09 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.09 | Why? |
| Male | 11 | 2020 | 367725 | 0.09 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.09 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.09 | Why? |
| Female | 10 | 2020 | 380317 | 0.08 | Why? |
| Middle Aged | 8 | 2020 | 270681 | 0.08 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.08 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Lymphocyte Count | 1 | 2018 | 4758 | 0.08 | Why? |
| Workplace | 1 | 2018 | 2075 | 0.08 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Glucocorticoids | 2 | 2018 | 4431 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2019 | 2510 | 0.07 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.07 | Why? |
| Occupational Stress | 1 | 2018 | 2044 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.06 | Why? |
| Adult | 6 | 2020 | 244371 | 0.06 | Why? |
| Occupational Diseases | 1 | 2018 | 2787 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.05 | Why? |
| Immunoassay | 1 | 2016 | 4485 | 0.05 | Why? |
| Moscow | 1 | 2020 | 246 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Coccyx | 1 | 2019 | 2 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| Perineum | 1 | 2019 | 70 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.04 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2018 | 219 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.04 | Why? |
| Preventive Medicine | 1 | 2018 | 242 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.03 | Why? |
| Death, Sudden, Cardiac | 1 | 2019 | 522 | 0.03 | Why? |
| Aged | 2 | 2020 | 215776 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Patients | 1 | 2020 | 1167 | 0.03 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Heart Rate | 1 | 2019 | 1527 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2018 | 3567 | 0.02 | Why? |
| Risk | 1 | 2019 | 5288 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |